Select Publications
Journal articles
2001, 'In vitro and preclinical studies of targeted alpha therapy for human breast cancer using 213Bi-labeled-plasminogen activator inhibitor type 2', EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 28, pp. 1191 - 1191, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000170528300888&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers', Critical Reviews in Oncology/Hematology, 39, pp. 139 - 146, http://dx.doi.org/10.1016/S1040-8428(01)00113-5
,2001, 'Mast cell/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5 and CXCR4', Blood, pp. 3484 - 3490
,2000, 'Identification of a novel population of mast cells/basophils in human periphal blood of allergic patients which is HIV-1 susceptible due to its surface expression of CD4, CCR5, and CXCR4', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 105, pp. S86 - S87, http://dx.doi.org/10.1016/S0091-6749(00)90690-0
,1999, 'Monoclonal antibodies recognizing antigens expressed in human mast cells and their progenitors', FASEB JOURNAL, 13, pp. A337 - A337, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082033301949&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Cells that have features of both mast cells and basophils in the peripheral blood of allergy, asthma, and drug reactive', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 103, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000078509000169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Monoclonal antibodies recognizing antigens expressed in human mast cells and their progenitors.', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 103, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000078509000170&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension', The Journal of Biological Chemistry, pp. 30784 - 30793
,1998, 'Identification of Basophilic Cells that Express Mast Cell Granule Proteases in the Peripheral Blood of Asthma, Allergy, and Drug-Reactive Patients', Journal of Immunology, 161, pp. 5079 - 5086
,Conference Papers
2019, 'Abstract 4754: CHTOP is a novel therapeutic target for chemoresistant epithelial ovarian cancer therapy', in Cancer Research, American Association for Cancer Research (AACR), pp. 4754 - 4754, http://dx.doi.org/10.1158/1538-7445.am2019-4754
,2018, 'Study of CD44 variant 6 (CD44v6) in prostate cancer chemo-/radio resistance in vivo', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-1999
,2017, 'Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer progression and chemo/radio-resistance in vitro and in vivo', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 01 April 2017 - 05 April 2017, http://dx.doi.org/10.1158/1538-7445.AM2017-2833
,2014, 'CD44 isoform variant 6 is associated with prostate cancer progression, metastasis and chemo-/radio-resistance via PI3K/Akt/mTOR and Wnt/beta-catenin signaling pathways in vitro', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-4005
,2008, 'Backward probabilistic logic reasoning algorithm for decision problem with conditional event algebra on bayesian networks', in Proceedings of the 7th International Conference on Machine Learning and Cybernetics, ICMLC, pp. 1744 - 1749, http://dx.doi.org/10.1109/ICMLC.2008.4620687
,2008, 'Identification of the potential biomakers for prostate cancer from tears and sera using proteomic methods', in The 13th Annual Proteomics Symposium Erskine Mantra Resort, Lorne , VIC, presented at 13th Annual Proteomics Symposium Erskine Mantra Resort, Lorne , VIC, 08 February 2008 - 10 February 2008
,2006, 'Control of DU 145 and LNCaP-LN3 prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates', in Annals of Oncology, Oxford Univ Press, Oxford, England, presented at Symposium on targeted anticancer therapies, Amsterdam, 16 March 2006 - 18 March 2006, http://dx.doi.org/10.1093/annonc/mdl921
,2004, 'In Vitro Targeting of NG2 antigen by 213Bi-9.2.27 radioimmunoconjugate induces cytotoxicity in human uveal melanoma cells', presented at XVI international congress of eye research, 29 August 2004 - 03 September 2004
,2004, 'Antigenic Expression of Human Metastatic Prostate Cancer Cell Lines and Primary Prostate Cancer Sections for In Vitro Multiple Targeted Alpha Therapy with 213Bi-conjugates.', presented at 95th AACR annual meeting, 27 March 2004 - 31 March 2004
,2003, '213Bi-PAI2 conjugate selectively induced apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model', presented at 12th International Congress of Radiation Research, 17 September 2003 - 22 September 2003
,2003, 'Evaluation of preclinical single and multiple dose toxicity and efficacy of 213Bi-labeled plasminogen activator inhibitor 2 for breast and prostate cancer.', 17 September 2003 - 22 September 2003
,2003, 'In vitro and in vivo targeted alpha therapy (TAT) of colorectal cancer using monoclonal antibodies c30 and 35A7', presented at 12th International Congress of Radiation Research, 17 September 2003 - 22 September 2003
,2003, 'In vitro cytotoxicity of alpha conjugates for human pancreatic cancer cell lines', presented at 12th International Congress of Radiation Research, 17 September 2003 - 22 September 2003
,2003, 'Targeted alpha therapy for human prostate cancer cell lines in vitro using -particle emitter (213Bi)-labeled Herceptin.', presented at 12th International Congress of Radiation Research, 17 September 2003 - 22 September 2003
,Conference Posters
2005, 'Promise of BLCA-38 as a targeting antibody for tissue specific gene delivery to prostate cancer', Vol. 7, pp. 1130 - 1130, presented at 4th Meeting of the Australasian Gene Therapy Society, 27 April 2005 - 29 April 2005, http://dx.doi.org/10.1002/jgm.808
,Conference Presentations
2012, 'Identification of novel urine biomarkers from metastatic breast cancer patients using proteomic approaches.', presented at Asia Oceania Human Proteome Organization (AOHUPO) 6th Congress, China National Convention Center, Beijing, China, 05 May 2012 - 07 May 2012
,2012, 'CD44 and CD147 expression influence prostate cancer chemoresistance and metastasis', presented at The Australian Society for Medical Research (ASMR), Sydney, Australia, -
,2010, 'Identification of potential biomarkers for prostate cancer in tears and serum using proteomic approaches', presented at The Inaugural Biomarker Discovery Conference, Port Stephens NSW Australia, 06 December 2010 - 10 December 2010
,2010, 'Identification of potential biomarkers for prostate cancer in tears and serum using proteomic approaches', presented at HUPO-9th Annual World Congress, Sydney, Australia, 19 September 2010 - 23 September 2010
,2010, 'CD44 and CD147 in prostate cancer metastasis and chemoresistance', presented at Sixth International Symposium on Hormonal Oncogenesis, Tokyo, Japan, 12 September 2010 - 16 September 2010
,2010, 'Using proteomic approaches to identify potential biomarkers for prostate cancer in tears and serum', presented at 3rd Annual World Cancer Congress, Singapore, 22 June 2010 - 25 June 2010
,Conference Abstracts
2022, 'Isolation of exosomal microRNA to serve as a diagnostic biomarker for prostate cancer: A provisional analysis of 12 patients', in BJU INTERNATIONAL, WILEY, AUSTRALIA, Gold Coast, Vol. 129, pp. 140 - 140, presented at Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, AUSTRALIA, Gold Coast, 25 June 2022 - 28 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000808481200227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Studying CD44 variant 6 (CD44v6) in prostate cancer progression and chemo-/radio-resistance using in vivo mouse models', in Annals of Oncology, Vol. 28, pp. x78 - x79, http://dx.doi.org/10.1093/annonc/mdx662.006
,2015, 'Combination of LBH589 and radiotherapy overcomes radioresistance in radioresistant prostate cancer cells in vitro and animal models in vivo', in BJU INTERNATIONAL, WILEY-BLACKWELL, AUSTRALIA, Cairns, Vol. 116, pp. 33 - 34, presented at 2nd Prostate Cancer World Congress (PCWC), AUSTRALIA, Cairns, 17 August 2015 - 21 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359254200095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer chemo-/radio-resistance in cell lines in vitro and in animal models in vivo', in BJU INTERNATIONAL, WILEY-BLACKWELL, AUSTRALIA, Cairns, Vol. 116, pp. 31 - 31, presented at 2nd Prostate Cancer World Congress (PCWC), AUSTRALIA, Cairns, 17 August 2015 - 21 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359254200087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Identification of lactate dehydrogenase A (LDHA) as a potential therapeutic target for prostate cancer radiotherapy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-2001
,Theses / Dissertations
2000, A study of human mast cell origin and differentiation
,